Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Song

Showing results (191-200 of 252) with videos related to

Pageof 26
Sort By:
International Immunopharmacology|March 31, 2023
CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewingYadan Li, Haixia Cao, Zhongxing Jiang, et al.
Eclinicalmedicine|July 15, 2024
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trialYuankai Shi, Keshu Zhou, Hui Zhou, et al.
Zhonghua Yi Xue Za Zhi|June 12, 2022
[Analysis the influence factors of treatment free remission outcome with chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitors]H F Zhao, Yanli Zhang, L X Dang, et al.
Scientific Reports|January 9, 2021
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAAYingling Zu, Jian Zhou, Yuewen Fu, et al.
Experimental Hematology & Oncology|May 9, 2023
Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencingWei Li, Binglei Zhang, Weijie Cao, et al.
Bone Marrow Transplantation|July 15, 2022
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trialYingling Zu, Zhen Li, Ruirui Gui, et al.
Bone Marrow Transplantation|March 25, 2023
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemiaJixin Fan, Runqing Lu, Jingkui Zhu, et al.
Leukemia Research|March 27, 2007
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinibBaijun Fang, Yongping Song, Zhengtao Han, et al.
Frontiers in Plant Science|November 17, 2022
Rice microtubule-associated protein OsMAP65-3.1, but not OsMAP65-3.2, plays a critical role in phragmoplast microtubule organization in cytokinesisXiaoli Lin, Yu Xiao, Yongping Song, et al.
Journal of Hematology & Oncology|February 5, 2016
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancerZibing Wang, Yuqing Liu, Rui'e Li, et al.
Pageof 26

Showing results (191-200 of 252) with videos related to

Sort By:
Pageof 26
International Immunopharmacology|March 31, 2023
CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewingYadan Li, Haixia Cao, Zhongxing Jiang, et al.
Eclinicalmedicine|July 15, 2024
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trialYuankai Shi, Keshu Zhou, Hui Zhou, et al.
Zhonghua Yi Xue Za Zhi|June 12, 2022
[Analysis the influence factors of treatment free remission outcome with chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitors]H F Zhao, Yanli Zhang, L X Dang, et al.
Scientific Reports|January 9, 2021
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAAYingling Zu, Jian Zhou, Yuewen Fu, et al.
Experimental Hematology & Oncology|May 9, 2023
Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencingWei Li, Binglei Zhang, Weijie Cao, et al.
Bone Marrow Transplantation|July 15, 2022
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trialYingling Zu, Zhen Li, Ruirui Gui, et al.
Bone Marrow Transplantation|March 25, 2023
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemiaJixin Fan, Runqing Lu, Jingkui Zhu, et al.
Leukemia Research|March 27, 2007
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinibBaijun Fang, Yongping Song, Zhengtao Han, et al.
Frontiers in Plant Science|November 17, 2022
Rice microtubule-associated protein OsMAP65-3.1, but not OsMAP65-3.2, plays a critical role in phragmoplast microtubule organization in cytokinesisXiaoli Lin, Yu Xiao, Yongping Song, et al.
Journal of Hematology & Oncology|February 5, 2016
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancerZibing Wang, Yuqing Liu, Rui'e Li, et al.
Pageof 26